We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.61%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22B
AUM Growth
-$123M
(-0.55%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$62M |
| 2 |
UBS Group
UBS
|
+$49.7M |
| 3 |
Air Products & Chemicals
APD
|
+$47.3M |
| 4 |
AT&T
T
|
+$44.6M |
| 5 |
Lam Research
LRCX
|
+$39.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$61.6M |
| 2 |
HCA Healthcare
HCA
|
+$50.8M |
| 3 |
Gen Digital
GEN
|
+$50.7M |
| 4 |
Baxter International
BAX
|
+$50.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 11.57% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEWR
501
DELISTED
New Relic, Inc.
NEWR
| $6.8M | 0.03% |
158,000
+13,000
| +9% | +$541K |
|
502
Humana
HUM
$47.6B
| $6.76M | 0.03% |
28,100
+1,200
| +4% | +$272K |
|
503
International Flavors & Fragrances
IFF
$21.5B
| $6.7M | 0.03% |
49,600
-500
| -1% | -$67.8K |
|
504
Bunge Global
BG
$23.4B
| $6.68M | 0.03% |
89,500
-226,430
| -72% | -$17.2M |
|
505
Las Vegas Sands
LVS
$26.7B
| $6.64M | 0.03% |
103,902
+3,549
| +4% | +$213K |
|
|
MDSO
506
DELISTED
Medidata Solutions, Inc.
MDSO
| $6.62M | 0.03% |
84,700
-24,800
| -23% | -$1.73M |
|
507
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.5B
| $6.61M | 0.03% |
133,170
+3,650
| +3% | +$179K |
|
|
ARRY
508
DELISTED
Array Biopharma Inc
ARRY
| $6.61M | 0.03% |
789,255
+133,481
| +20% | +$1.09M |
|
509
iShares Core S&P Total US Stock Market ETF
ITOT
$95.1B
| $6.58M | 0.03% |
118,780
+70
| +0.1% | +$3.84K |
|
|
VMRK
510
Vivmark Residential
VMRK
$50.8B
| $6.55M | 0.03% |
99,572
-308,995
| -76% | -$20.2M |
|
511
Quest Diagnostics
DGX
$27.3B
| $6.48M | 0.03% |
58,300
+26,500
| +83% | +$2.8M |
|
512
American Airlines Group
AAL
$8.45B
| $6.48M | 0.03% |
128,692
-381,745
| -75% | -$17.7M |
|
513
Itron
ITRI
$4.04B
| $6.46M | 0.03% |
95,300
-400
| -0.4% | -$26.2K |
|
514
Insmed
INSM
$26.2B
| $6.43M | 0.03% |
374,773
-81,767
| -18% | -$1.4M |
|
|
ZNGA
515
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $6.4M | 0.03% |
1,758,600
-78,000
| -4% | -$256K |
|
516
East-West Bancorp
EWBC
$17.6B
| $6.4M | 0.03% |
109,182
-33,217
| -23% | -$1.83M |
|
517
iShares S&P 100 ETF
OEF
$20.1B
| $6.35M | 0.03% |
59,402
| – | – |
|
518
CoreCivic
CXW
$3.5B
| $6.34M | 0.03% |
230,000
-4,100
| -2% | -$128K |
|
|
LHO
519
DELISTED
LaSalle Hotel Properties
LHO
| $6.34M | 0.03% |
212,720
-58,000
| -21% | -$1.7M |
|
520
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $6.33M | 0.03% |
155,100
-3,900
| -2% | -$158K |
|
|
SF
521
Stifel
SF
$11.6B
| $6.32M | 0.03% |
309,375
+211,500
| +216% | +$4.34M |
|
|
LPNT
522
DELISTED
LifePoint Health, Inc.
LPNT
| $6.32M | 0.03% |
94,102
-529
| -0.6% | -$33.4K |
|
523
World Kinect Corp
WKC
$1.82B
| $6.3M | 0.03% |
163,900
+101,400
| +162% | +$3.71M |
|
524
Kinder Morgan
KMI
$68.5B
| $6.29M | 0.03% |
328,133
-34,795
| -10% | -$692K |
|
525
Marriott Vacations Worldwide
VAC
$3.48B
| $6.22M | 0.03% |
52,845
+50,745
| +2,416% | +$5.73M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2017 Portfolio in Review
As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Element Solutions worth $22.3M.
- Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
- Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
- Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
- Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
- Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
- Axa opened 101 new positions and closed 125 in Q2 2017.
- Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.
Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.